Fingerprint
Dive into the research topics of 'A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
Daniel J. Ma, Evanthia Galanis, S. Keith Anderson, David Schiff, Timothy J. Kaufmann, Patrick J. Peller, Caterina Giannini, Paul D. Brown, Joon H. Uhm, Steven McGraw, Kurt A. Jaeckle, Patrick J. Flynn, Keith L. Ligon, Jan C. Buckner, Jann N. Sarkaria
Research output: Contribution to journal › Article › peer-review
75
Scopus
citations